Legislation surrounding the sourcing of human biosamples varies around the world. Join us on February 23 as Cureline Global Translational CRO discusses legislation, standards and due diligence when sourcing HBS in India. Register today at https://t.co/C9XvafGYCn
CEO Dr. Olga Potapova talks about the importance of Biobanking and Contract services at the U.S.
Biopharmaceuticals 2018, Global Business ReportsGB Reports United States Biopharmaceuticals 2018 Pre-Release https://t.co/Q8BukGi6Xl
#ISBER meeting in Luxembourg is on! Dr. Olga Potapova, Cureline CEO and Scientific Director, is among scientists from around the world that are discussing how to make precision medicine precise by providing fit-for-purpose samples for developing efficient biomarkers and drugs.
Cureline participated in the Precision LBx conference in San Diego. Discussing today the Lung Cancer mutation landscape and CDx for targeted treatment for patients.
Cureline will be exhibiting at the Precision Medicine LbX Summit in San Diego on Jan 30-31 2018, stop by Cureline and meet our CEO Olga Potapova and project manager Vladislav and learn about us.
https://t.co/gehkI9vX38
1 day to go for the Precision: Blood Cancer Summit taking place in Crowne Plaza, San Francisco Airport! Visit @Cureline_Inc and meet our Director Harminder Singh, MD to discuss your #Biospecimen needs!
https://t.co/lmSblVuXz9